产品中心

PRODUCTS

Current location:Home >> 产品中心 >> 抗体

PRODUCT CLASSIFICATION

News

NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
帕利珠单抗
CFZ02295
palivizumab
188039-54-5
95%
那他珠单抗
CFZ02294
Natalizumab
189261-10-7
95%
阿泊珠单抗
CFZ02293
Apolizumab
267227-08-7
95%
托西珠单抗
CFZ02292
Eculizumab
219685-50-4
95%
莫维珠单抗
CFZ02291
Motavizumab
677010-34-3
95%
塞妥昔单抗
CFZ02290
Siltuximab
541502-14-1
95%
帕巴库单抗
CFZ02279
Panobacumab
885053-97-4
95%
索土珠单抗
CFZ02278
Epitumomab
372075-37-1
95%
奥英妥珠单抗
CFZ02277
notuzumab
635715-01-4
95%
艾韦单抗
CFZ02276
Exbivirumab
569658-80-6
95%
Service Hotline：
15111215862
18229892877